Literature DB >> 2206882

A clinicopathological study of 24 children with hemolytic uremic syndrome. A report of the Southwest Pediatric Nephrology Study Group.

J C Argyle1, R J Hogg, T J Pysher, F G Silva, R L Siegler.   

Abstract

This study reports the pattern of renal injury in 24 North American children with hemolytic uremic syndrome (HUS), and the extent of extrarenal involvement in 9 of these children examined at autopsy. Fifteen of the 24 children were studied during the first 16 days of hospitalization; their renal specimens demonstrated glomerular thrombotic microangiopathy (TMA) in 8 children, cortical necrosis in 1, and varying degrees of glomerular TMA and cortical necrosis in 6 children. Nine of the children were studied after 16 or more days of hospitalization; these patients had prominent renal arterial lesions. Of 9 children examined at autopsy, extrarenal microthrombi were identified in 8. In 4 children who died during the acute phase of the disease, hemorrhagic colonic necrosis (3 children) and pancreatic islet cell necrosis (2 children) were the principal extrarenal lesions encountered. Rare microthrombi were present in the brains of the 3 children who manifested seizures.

Entities:  

Mesh:

Year:  1990        PMID: 2206882     DOI: 10.1007/bf00858440

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  9 in total

1.  [Hemolytic-uremic syndrome: bilateral necrosis of the renal cortex in acute acquired hemolytic anemia].

Authors:  C GASSER; E GAUTIER; A STECK; R E SIEBENMANN; R OECHSLIN
Journal:  Schweiz Med Wochenschr       Date:  1955-09-20

2.  The hemolytic-uremic syndrome.

Authors:  C A Gianantonio; M Vitacco; F Mendilaharzu; G E Gallo; E T Sojo
Journal:  Nephron       Date:  1973       Impact factor: 2.847

3.  Hemolytic uremic syndrome--then and now.

Authors:  K N Drummond
Journal:  N Engl J Med       Date:  1985-01-10       Impact factor: 91.245

Review 4.  HUS and TTP: variable expression of a single entity.

Authors:  G Remuzzi
Journal:  Kidney Int       Date:  1987-08       Impact factor: 10.612

5.  Recurrent hemolytic-uremic syndrome with the hypomorphic fast allele of the third component of complement.

Authors:  R J Wyatt; D Jones; F B Stapleton; S Roy; T W Odom; R H McLean
Journal:  J Pediatr       Date:  1985-10       Impact factor: 4.406

6.  Endotheliotropic (hemolytic) nephroangiopathy and its various manifestation forms (thrombotic microangiopathy, primary malignant nephrosclerosis, hemolytic-uremic syndrome).

Authors:  W Thoenes; H D John
Journal:  Klin Wochenschr       Date:  1980-02-15

7.  Necrosis of the pancreas in the haemolytic uraemic syndrome.

Authors:  R A Primhak; L S Taitz; S Variend; D H Webb; A Cser
Journal:  J Clin Pathol       Date:  1984-06       Impact factor: 3.411

8.  The importance of nonrenal involvement in hemolytic-uremic syndrome.

Authors:  K Upadhyaya; K Barwick; M Fishaut; M Kashgarian; N J Siegel
Journal:  Pediatrics       Date:  1980-01       Impact factor: 7.124

9.  A clinico-pathologic study of crescentic glomerulonephritis in 50 children. A report of the Southwest Pediatric Nephrology Study Group.

Authors: 
Journal:  Kidney Int       Date:  1985-02       Impact factor: 10.612

  9 in total
  21 in total

1.  Inhibition of neutrophil apoptosis by verotoxin 2 derived from Escherichia coli O157:H7.

Authors:  J Liu; T Akahoshi; T Sasahana; H Kitasato; R Namai; T Sasaki; M Inoue; H Kondo
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

2.  Shiga-toxigenic Escherichia coli-inoculated neonatal piglets develop kidney lesions that are comparable to those in humans with hemolytic-uremic syndrome.

Authors:  J F Pohlenz; K R Winter; E A Dean-Nystrom
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

Review 3.  Trials and tribulations of multicenter studies. Lessons learned from the experiences of the Southwest Pediatric Nephrology Study Group (SPNSG).

Authors:  R J Hogg
Journal:  Pediatr Nephrol       Date:  1991-05       Impact factor: 3.714

4.  Long-term investigation of kidney ultrasound in cases of hemolytic uremic syndrome in children.

Authors:  Thi Thanh Tam Bui; Heiko Billing; Abdulsattar Alrajab; Elke Wühl; Jens-Peter Schenk
Journal:  J Med Ultrason (2001)       Date:  2013-10-22       Impact factor: 1.314

5.  Diffusion-weighted imaging of the kidneys in haemolytic uraemic syndrome.

Authors:  Jochen Herrmann; Ulrich Wenzel; Stephanie Galler; Bjoern P Schoennagel; Jasmin D Busch; Magdalini Tozakidou; Kay U Petersen; Michaela Joekel; Peter Bannas; Jin Yamamura; Michael Groth; Gerhard Adam; Christian R Habermann
Journal:  Eur Radiol       Date:  2017-05-12       Impact factor: 5.315

6.  Hemolytic uremic syndrome-associated Shiga toxins promote endothelial-cell secretion and impair ADAMTS13 cleavage of unusually large von Willebrand factor multimers.

Authors:  Leticia H Nolasco; Nancy A Turner; Aubrey Bernardo; Zhenyin Tao; Thomas G Cleary; Jing-Fei Dong; Joel L Moake
Journal:  Blood       Date:  2005-08-30       Impact factor: 22.113

7.  Management of patients with hemolytic uremic syndrome demonstrating severe azotemia but not anuria.

Authors:  S L Schulman; B S Kaplan
Journal:  Pediatr Nephrol       Date:  1996-10       Impact factor: 3.714

8.  Differences in verotoxin neutralizing activity of therapeutic immunoglobulins and sera from healthy controls.

Authors:  M Bitzan; M Klemt; R Steffens; D E Müller-Wiefel
Journal:  Infection       Date:  1993 May-Jun       Impact factor: 3.553

9.  Troponin I levels in a hemolytic uremic syndrome patient with severe cardiac failure.

Authors:  Varvara Askiti; Kristine Hendrickson; Alfred J Fish; Elizabeth Braunlin; Alan R Sinaiko
Journal:  Pediatr Nephrol       Date:  2003-12-18       Impact factor: 3.714

10.  Cardiac failure in hemolytic uremic syndrome and rescue with extracorporeal life support.

Authors:  N J Thomas; J J Messina; W J DeBruin; J A Carcillo
Journal:  Pediatr Cardiol       Date:  2005 Jan-Feb       Impact factor: 1.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.